Peroxisome biogenesis and human peroxisome assembly disorders : Approches to prenatal diagnosis and gene therapy.
过氧化物酶体生物合成和人类过氧化物酶体组装障碍:产前诊断和基因治疗方法。
基本信息
- 批准号:08557011
- 负责人:
- 金额:$ 10.69万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A)
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
With the support of this Grants-in Aid for Scientific Research 0 8 5 5 7 0 1 1 we obtained two major types of findings :I) Isolation, characterization, and complementation group analysis of novel CHO cell mutants defective in peroxisome biogenesisIn addition to the previously isolated, three complementation groups (CGs) of peroxisome-deficient CHO cell mutants, ZP24, Z65, and ZP92, we isolated ZPlO7 (the same group as Z24), ZP1O5/ZP139, ZPIO9, ZP11O, ZP114, ZP119, ZP124, and ZP126, by the P9OH/UV method. CG analysis by PEX cDNA transfection and/or cell fusion with previously identified CGs of mutant cells, including 12 CGs of fibroblasts derived from patients with peroxisome biogenesis disorders (PBDs), revealed that ZP110, ZP114, and ZP126 are distinct from human CGs. Thus, it is evident that peroxisome assembly requires at least 15 gene-products.II) Cloning of novel peroxin genes By genetic functional complementation assay of newly isolated CHO cell mutants, we cloned several peroxin cDNAs (PEXs), including PEX1, PEX12, and PEX19 for ZP1O7, ZP1O9, and ZP119, respectively. We then delineated that gene mutations in PEX1, PEX12, and PEX19 are responsible for PBDs of CG-I (E), CG-III, and CG-J, respectively. Moreover, we isolated PEX1O and PEX16 by expressed sequence tag (EST) DNA search using yeast genes and demonstrated that inactivation of PEX]O and PEX16 is the genetic cause of CG-VII (B) and CG-IX (D) PBDs, respectively. We also found two isoforms of the peroxin Pex5p (PTS 1 receptor) using CG-ll CHO mutants, ZP1O5 and ZP139. Impaired import of PTS1 proteins in the mutant cells was restored by both, shorter and longer, forms of Pex5p. More strikingly, the longer isoform of Pex5p was found to be involved in import of PTS2 proteins as well.
With the support of this Grants-in Aid for Scientific Research 0 8 5 5 7 0 1 1 we obtained two major types of findings :I) Isolation, characterization, and complementation group analysis of novel CHO cell mutants defective in peroxisome biogenesisIn addition to the previously isolated, three complementation groups (CGs) of peroxisome-deficient CHO cell mutants, ZP24, Z65, and ZP92, we isolated ZPlO7 (the same组通过P9OH/UV方法为Z24),ZP1O5/ZP139,ZPIO9,ZP11O,ZP114,ZP119,ZP124和ZP126。 CG通过PEX cDNA转染和/或细胞融合与先前鉴定的突变细胞的CG分析,包括来自过氧化物酶体生物发生障碍患者(PBD)的12个CG的成纤维细胞(PBD),显示ZP110,ZP114和ZP126与人类CG有所不同。因此,很明显,过氧化物组组装需要至少15个基因产物。II)通过新分离的CHO细胞突变体的遗传功能补体测定法克隆新型过氧蛋白基因,我们将几个过氧蛋白CDNA(PEXS)克隆了,包括PEX1,PEX12,PEX12,和PEX19,用于ZP1O7,ZP1O7,ZP1O9,和ZP1O9,和ZP1O9,和ZP1O9,和ZP1O9,和ZP1O9,和ZP1O。然后,我们描述了PEX1,PEX12和PEX19中的基因突变分别负责CG-I(E),CG-III和CG-J的PBD。此外,我们使用酵母基因通过表达的序列TAG(EST)DNA搜索分离了PEX1O和PEX16,并证明PEX] O和PEX16分别是CG-VII(B)和CG-IX(B)和CG-IX(D)PBD的遗传原因。我们还使用CG-LL CHO突变体ZP1O5和ZP139发现了两种过氧蛋白PEX5P(PTS 1受体)的同工型。 PEX5P的较短和更长的形式恢复了突变细胞中PTS1蛋白的进口受损。更引人注目的是,发现PEX5P的同工型也涉及PTS2蛋白的进口。
项目成果
期刊论文数量(74)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Fujiki,Y.: "Peroxisome Biogenesis:Topogenic Signal,Peroxisome Assembly Factor,and Zellweger Syndrome.In Membrane Protein Transport(S.Rothman,ed.)" Advances in Molecular and Cell Biology, 213-219 (1996)
Fujiki,Y.:“过氧化物酶体生物发生:拓扑信号、过氧化物酶体组装因子和 Zellweger 综合征。膜蛋白转运(S.Rothman,编辑)”分子和细胞生物学进展,213-219(1996)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Okumoto,K.: "Isolation and characterization of peroxisome-deficient Chinese hamster ovary (CHO) cell mutants representing human complementation group III." Exp.Cell Res.233. 11-20 (1997)
Okumoto,K.:“代表人类互补组 III 的过氧化物酶体缺陷型中国仓鼠卵巢 (CHO) 细胞突变体的分离和表征。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Okumoto,K.: "PEX12 encodes an integral membrane protein of peroxisomes." Nature Genet.17. 265-266 (1997)
Okumoto,K.:“PEX12 编码过氧化物酶体的整合膜蛋白。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shimozawa,N.: "A novel mutation,R125X in peroxisome assembly factor-1 responsible for Zellweger syndrome." Hum.Mut.(in press). (1997)
Shimozawa,N.:“过氧化物酶体组装因子 1 中的一种新突变 R125X 导致齐薇格综合征。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Abe,I.: "Clofibrate-inducible,28-kDa peroxisomal integral membrane protein is encoded by PEXII." FEBS Lett.431. 468-472 (1998)
Abe,I.:“氯贝特诱导型 28-kDa 过氧化物酶体整合膜蛋白由 PEXII 编码。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FUJIKI Yukio其他文献
FUJIKI Yukio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FUJIKI Yukio', 18)}}的其他基金
Structure and Function of Peroxins Essential for Peroxisome Assembly
过氧化物酶体组装所必需的过氧化物酶的结构和功能
- 批准号:
20370039 - 财政年份:2008
- 资助金额:
$ 10.69万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular Anatomy of Peroxisome Biogenesis and Human Disorders
过氧化物酶体生物发生和人类疾病的分子解剖学
- 批准号:
15207014 - 财政年份:2003
- 资助金额:
$ 10.69万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Peroxisome biogenesis and human peroxisome biogenesis disorders
过氧化物酶体生物发生和人类过氧化物酶体生物发生障碍
- 批准号:
12308033 - 财政年份:2000
- 资助金额:
$ 10.69万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Peroxisome biogenesis and human peroxisome biogenesis disorders: Approaches to prenatal diagnosis and gene therapy
过氧化物酶体生物发生和人类过氧化物酶体生物发生障碍:产前诊断和基因治疗方法
- 批准号:
12557017 - 财政年份:2000
- 资助金额:
$ 10.69万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Studies on Perxisome Biogenesis and Peroxisomal Disorders
过氧化物酶体生物发生和过氧化物酶体疾病的研究
- 批准号:
09044094 - 财政年份:1997
- 资助金额:
$ 10.69万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Peroxisome biogenesis and human eroxisome assembly disorders.
过氧化物酶体生物发生和人类过氧化物酶体组装障碍。
- 批准号:
07408016 - 财政年份:1995
- 资助金额:
$ 10.69万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
相似海外基金
Identification of novel PEX gene and functional analysis of Pexlp in peroxisome biogenesis
新型PEX基因的鉴定及Pexlp在过氧化物酶体生物合成中的功能分析
- 批准号:
13680694 - 财政年份:2001
- 资助金额:
$ 10.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Peroxisome biogenesis and human peroxisome biogenesis disorders: Approaches to prenatal diagnosis and gene therapy
过氧化物酶体生物发生和人类过氧化物酶体生物发生障碍:产前诊断和基因治疗方法
- 批准号:
12557017 - 财政年份:2000
- 资助金额:
$ 10.69万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Peroxisome biogenesis and human peroxisome biogenesis disorders
过氧化物酶体生物发生和人类过氧化物酶体生物发生障碍
- 批准号:
12308033 - 财政年份:2000
- 资助金额:
$ 10.69万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Studies on Perxisome Biogenesis and Function of Pex1p
Pex1p过氧化物酶体的生物发生及功能研究
- 批准号:
11680608 - 财政年份:1999
- 资助金额:
$ 10.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on Perxisome Biogenesis and Peroxisomal Disorders
过氧化物酶体生物发生和过氧化物酶体疾病的研究
- 批准号:
09044094 - 财政年份:1997
- 资助金额:
$ 10.69万 - 项目类别:
Grant-in-Aid for Scientific Research (B).